{"title":"罗扎尼珠单抗治疗全身性肌无力:使用概况","authors":"Sheridan M. Hoy","doi":"10.1007/s40267-024-01077-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":267536,"journal":{"name":"Drugs & Therapy Perspectives","volume":"120 40","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rozanolixizumab in generalized myasthenia gravis: a profile of its use\",\"authors\":\"Sheridan M. Hoy\",\"doi\":\"10.1007/s40267-024-01077-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":267536,\"journal\":{\"name\":\"Drugs & Therapy Perspectives\",\"volume\":\"120 40\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs & Therapy Perspectives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40267-024-01077-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Therapy Perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40267-024-01077-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}